featured
Association Between HER2 Expression and Prognosis in Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group
ESMO Open 2023 Feb 01;8(1)100747, SP Gampenrieder, V Dezentjé, M Lambertini, A de Nonneville, M Marhold, F Le Du, A Cortés Salgado, D Alpuim Costa, M Vaz Batista, N Chic Ruché, C Tinchon, A Petzer, E Blondeaux, L Del Mastro, G Targato, F Bertucci, A Gonçalves, F Viret, R Bartsch, C Mannsbart, A Deleuze, L Robert, C Saavedra Serrano, M Gion Cortés, M Sampaio-Alves, M Vitorino, L Pecen, C Singer, N Harbeck, G Rinnerthaler, R GreilFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.